* Rupee ends at 60.13/14 vs 60.215/225 Wednesday close
* India cbank chief says not to protect any particular FX rate
* INR seen rising around 4 pct to 57.50 in 12 months - Reuters poll
By Subhadip Sircar
MUMBAI, July 4 The Indian rupee eked out minor gains on Thursday, snapping three sessions of losses, but sentiment was dented after the Reserve Bank of India chief said the bank would not defend any particular exchange rate, which dealers read as likely absence of any heavy intervention.
RBI chief Duvvuri Subbarao's comments on the exchange rate, which would be read as innocuous in other circumstances, led to a sharp sell-off in the rupee, which the market took as a signal that any significant intervention was unlikely despite the currency hovering near record lows.
The absence of any strong comments from the governor to support the rupee was also a dampener for the markets, dealers said.
The rupee is likely to take its next cue from the U.S. non-farm payrolls data, due Friday, which will be an important data point for the Federal Reserve's decision to slow down its bond purchases.
"The RBI governor's comments on not protecting any particular rupee levels and concerns on the deficit did not go down well with the currency market," said Uday Bhatt, a senior manager at UCO Bank.
"The non-farm payrolls data will be the key. If it's strong, the rupee may see 61 levels."
The rupee was supported by a strong stock performance with local stocks gaining 1.2 percent.
The partially convertible rupee closed at 60.13/14, compared with its previous close of 60.215/225. It fell to as much as 60.38 after the governor's comments.
The battered Indian rupee will remain under pressure against the U.S. dollar over the next year as a wide current account deficit and policy inaction dissuades foreign investment into the country, a Reuters poll showed.
In the offshore non-deliverable forwards, the one-month contract was at 60.51, while the three-month was at 61.21.
In the currency futures market, the most-traded near-month dollar/rupee contracts on the National Stock Exchange, the MCX-SX and the United Stock Exchange all closed around 60.46 with a total traded volume of $4.9 billion. (Editing by Anand Basu)
Trending On Reuters
The U.S. Department of Justice (DoJ) has subpoenaed India's largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday. Full Article